The Effects of Cannabinoids on Sleep.
Kolla BP, Hayes L, Cox C, Eatwell L, Deyo-Svendsen M, Mansukhani MP.
J Prim Care Community Health. 2022 Jan-Dec;13:21501319221081277. doi: 10.1177/21501319221081277.
Clinical management of cannabis withdrawal.
Connor JP, Stjepanović D, Budney AJ, Le Foll B, Hall WD.
Addiction. 2022 Jul;117(7):2075-2095. doi: 10.1111/add.15743. Epub 2022 Jan 10.
Cannabis-Based Products for Chronic Pain : A Systematic Review.
McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R.
Ann Intern Med. 2022 Aug;175(8):1143-1153. doi: 10.7326/M21-4520. Epub 2022 Jun 7.
Cannabinoids and the Gastrointestinal Tract.
Camilleri M, Zheng T.
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3217-3229. doi: 10.1016/j.cgh.2023.07.031. Epub 2023 Sep 9.
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, Farrell M, Degenhardt L.
Lancet Psychiatry. 2019 Dec;6(12):995-1010. doi: 10.1016/S2215-0366(19)30401-8. Epub 2019 Oct 28.
The Psychiatric Consequences of Cannabinoids.
De Aquino JP, Sherif M, Radhakrishnan R, Cahill JD, Ranganathan M, D'Souza DC.
Clin Ther. 2018 Sep;40(9):1448-1456. doi: 10.1016/j.clinthera.2018.03.013. Epub 2018 Apr 17.
Focus on cannabinoids and synthetic cannabinoids.
Le Boisselier R, Alexandre J, Lelong-Boulouard V, Debruyne D.
Clin Pharmacol Ther. 2017 Feb;101(2):220-229. doi: 10.1002/cpt.563. Epub 2016 Dec 20.
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal.
Cooper ZD.
Curr Psychiatry Rep. 2016 May;18(5):52. doi: 10.1007/s11920-016-0694-1.
The cannabis withdrawal syndrome.
Budney AJ, Hughes JR.
Curr Opin Psychiatry. 2006 May;19(3):233-8. doi: 10.1097/01.yco.0000218592.00689.e5.
Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol.
Kudrich C, Hurd YL, Salsitz E, Wang AL.
Cannabis Cannabinoid Res. 2022 Oct;7(5):569-581. doi: 10.1089/can.2021.0089. Epub 2021 Oct 22.
